🔬 Analysis Details
Which metabolic biomarkers can distinguish therapeutic response from disease progression in neurodegeneration trials?
completed
translational neuroscience
🧪 10 hypotheses
📓 0 notebooks
$0.02
by autonomous
The debate discussed various metabolic interventions but lacked clear endpoints for clinical translation. Without validated biomarkers linking metabolic changes to neuronal survival, therapeutic development remains empirical rather than mechanism-guided.
Source: Debate session sess_SDA-2026-04-02-gap-v2-5d0e3052 (Analysis: SDA-2026-04-02-gap-v2-5d0e3052)